2024
DOI: 10.1016/j.bioactmat.2023.10.021
|View full text |Cite
|
Sign up to set email alerts
|

Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion

Xu Li,
Ningtao Cheng,
Danrong Shi
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…51 Using only heparin fragments (octasaccharide) ensured the removal of the unwanted anticoagulation activity characteristic for full-length heparin. Instead of oligomeric heparin fragments on liposomes, sulfated liposomes were created by incorporating cholesteryl sodium sulfate, 52 which achieved SARS-CoV-2 inhibition and inactivation, partially through fusion with virions, although much higher liposome concentrations were necessary compared to heparin octasaccharide-modified liposomes (Table 1). Other glycan-modified liposomes with pendant SA groups were also developed to function against IAV, with activity confirmed in mice with lethal IAV infection.…”
Section: Soft Matter-based Nanoscale Viral Inhibitorsmentioning
confidence: 99%
“…51 Using only heparin fragments (octasaccharide) ensured the removal of the unwanted anticoagulation activity characteristic for full-length heparin. Instead of oligomeric heparin fragments on liposomes, sulfated liposomes were created by incorporating cholesteryl sodium sulfate, 52 which achieved SARS-CoV-2 inhibition and inactivation, partially through fusion with virions, although much higher liposome concentrations were necessary compared to heparin octasaccharide-modified liposomes (Table 1). Other glycan-modified liposomes with pendant SA groups were also developed to function against IAV, with activity confirmed in mice with lethal IAV infection.…”
Section: Soft Matter-based Nanoscale Viral Inhibitorsmentioning
confidence: 99%